S&P 500   2,996.95 (+0.24%)
DOW   27,017.32 (+0.06%)
QQQ   193.25 (+0.11%)
AAPL   234.39 (+0.01%)
FB   189.58 (+0.02%)
MSFT   139.36 (-0.75%)
GOOGL   1,255.68 (+1.02%)
AMZN   1,789.36 (+0.67%)
CGC   19.98 (+1.27%)
NVDA   193.63 (-0.30%)
MU   45.48 (+0.71%)
BABA   176.62 (-0.28%)
T   37.73 (-0.16%)
F   9.12 (+0.55%)
BAC   30.26 (+0.30%)
GILD   65.29 (-0.09%)
DIS   133.40 (+1.94%)
S&P 500   2,996.95 (+0.24%)
DOW   27,017.32 (+0.06%)
QQQ   193.25 (+0.11%)
AAPL   234.39 (+0.01%)
FB   189.58 (+0.02%)
MSFT   139.36 (-0.75%)
GOOGL   1,255.68 (+1.02%)
AMZN   1,789.36 (+0.67%)
CGC   19.98 (+1.27%)
NVDA   193.63 (-0.30%)
MU   45.48 (+0.71%)
BABA   176.62 (-0.28%)
T   37.73 (-0.16%)
F   9.12 (+0.55%)
BAC   30.26 (+0.30%)
GILD   65.29 (-0.09%)
DIS   133.40 (+1.94%)
Log in

Ampio Pharmaceuticals Stock Price, News & Analysis (NYSEAMERICAN:AMPE)

$0.44
0.00 (0.00 %)
(As of 10/17/2019 11:33 AM ET)
Today's Range
$0.44
Now: $0.44
$0.45
50-Day Range N/A
52-Week Range
$0.36
Now: $0.44
$1.31
Volume2,604 shs
Average Volume790,547 shs
Market Capitalization$62.57 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Ampio Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. The company is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds. Its product pipeline includes Ampion, an intra-articular injection for the treatment of osteoarthritis of the knee. Read More…

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Biotechnology
Sub-IndustryPharmaceuticals
SectorMedical
Current SymbolNYSEAMERICAN:AMPE
CUSIP03209T10
Phone+1-720-4376500

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees22
Market Cap$62.57 million
Next Earnings Date11/13/2019 (Estimated)
OptionableOptionable

Receive AMPE News and Ratings via Email

Sign-up to receive the latest news and ratings for AMPE and its competitors with MarketBeat's FREE daily newsletter.


Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Frequently Asked Questions

What is Ampio Pharmaceuticals' stock symbol?

Ampio Pharmaceuticals trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "AMPE."

How were Ampio Pharmaceuticals' earnings last quarter?

Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) released its quarterly earnings data on Friday, August, 9th. The specialty pharmaceutical company reported ($0.03) earnings per share (EPS) for the quarter. View Ampio Pharmaceuticals' Earnings History.

When is Ampio Pharmaceuticals' next earnings date?

Ampio Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Wednesday, November 13th 2019. View Earnings Estimates for Ampio Pharmaceuticals.

Has Ampio Pharmaceuticals been receiving favorable news coverage?

Headlines about AMPE stock have trended very negative on Thursday, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Ampio Pharmaceuticals earned a daily sentiment score of -3.2 on InfoTrie's scale. They also gave headlines about the specialty pharmaceutical company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Ampio Pharmaceuticals.

Who are some of Ampio Pharmaceuticals' key competitors?

What other stocks do shareholders of Ampio Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ampio Pharmaceuticals investors own include Trevena (TRVN), Cerus (CERS), NovaBay Pharmaceuticals (NBY), Rigel Pharmaceuticals (RIGL), Synergy Pharmaceuticals (SGYP), AVEO Pharmaceuticals (AVEO), ImmunoGen (IMGN), Madrigal Pharmaceuticals (MDGL), NVIDIA (nvda) and AcelRx Pharmaceuticals (ACRX).

Who are Ampio Pharmaceuticals' key executives?

Ampio Pharmaceuticals' management team includes the folowing people:
  • Mr. Michael E. Macaluso, Founder, Chairman & CEO (Age 67)
  • Mr. Thomas E. Chilcott III, CFO, Treasurer & Sec. (Age 51)
  • Ms. Holli Cherevka, Chief Operating Officer (Age 36)

How do I buy shares of Ampio Pharmaceuticals?

Shares of AMPE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Ampio Pharmaceuticals' stock price today?

One share of AMPE stock can currently be purchased for approximately $0.44.

How big of a company is Ampio Pharmaceuticals?

Ampio Pharmaceuticals has a market capitalization of $62.57 million. Ampio Pharmaceuticals employs 22 workers across the globe.View Additional Information About Ampio Pharmaceuticals.

What is Ampio Pharmaceuticals' official website?

The official website for Ampio Pharmaceuticals is http://ampiopharma.com/.

How can I contact Ampio Pharmaceuticals?

Ampio Pharmaceuticals' mailing address is 373 Inverness Pkwy Ste 200, ENGLEWOOD, CO 80112-5898, United States. The specialty pharmaceutical company can be reached via phone at +1-720-4376500.


MarketBeat Community Rating for Ampio Pharmaceuticals (NYSEAMERICAN AMPE)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  138 (Vote Outperform)
Underperform Votes:  143 (Vote Underperform)
Total Votes:  281
MarketBeat's community ratings are surveys of what our community members think about Ampio Pharmaceuticals and other stocks. Vote "Outperform" if you believe AMPE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AMPE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/17/2019 by MarketBeat.com Staff

Featured Article: High-Yield Dividend Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel